REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Klinikiniai Sprendimai (Lithuania)

Main Activities: Scientific Research and Development Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: UAB Klinikiniai Sprendimai Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Klinikiniai Sprendimai is a company based in Lithuania, with its head office in Kaunas. The enterprise operates in the Scientific Research and Development Services industry. It was first established on September 22, 2005. It currently has a total number of 26 (2025) employees. There was a net sales revenue increase of 0.57% reported in UAB Klinikiniai Sprendimai’s latest financial highlights for 2024. UAB Klinikiniai Sprendimai’s net profit margin increased by 3.9% in 2024.

Headquarters
Vasarvietes g. 11M
Kaunas; Kaunas County; Postal Code: LT-44105

Contact Details: Purchase the UAB Klinikiniai Sprendimai report to view the information.

Basic Information
Total Employees:
Purchase the UAB Klinikiniai Sprendimai report to view the information.
Registered Capital:
Purchase the UAB Klinikiniai Sprendimai report to view the information.
Financial Auditors:
Purchase the UAB Klinikiniai Sprendimai report to view the information.
Incorporation Date:
September 22, 2005
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after UAB Klinikiniai Sprendimai report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
0.57%
Total operating revenue
0.57%
Net Profit (Loss) for the Period
57.85%
Total Equity
-50.27%
Net Profit Margin
3.9%
Return on Equity (ROE)
-85.84%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?